Giant Biogene Holding's latest marketcap:
As of 10/20/2025, Giant Biogene Holding's market capitalization has reached $5.63 B. According to our data, Giant Biogene Holding is the 3219th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 5.63 B |
| Revenue (ttm) | 862.01 M |
| Net Income (ttm) | 318.97 M |
| Shares Out | 1.07 B |
| EPS (ttm) | 0.31 |
| Forward PE | 14.06 |
| Ex-Dividend Date | 06/17/2025 |
| Earnings Date | 11/27/2025 |
Giant Biogene Holding's yearly market capitalization.
| Date | Market Cap(HK$) | Market Cap(USD) | Change (%) | Global Rank |
|---|---|---|---|---|
| 10/20/2025 | HK$43.76 B | $5.63 B | -14.09% | 3219 |
| 12/31/2024 | HK$50.36 B | $6.48 B | 44.94% | 2439 |
| 12/29/2023 | HK$34.75 B | $4.45 B | 5.95% | 3153 |
| 12/30/2022 | HK$32.79 B | $4.2 B | 3107 |
Company Profile
About Giant Biogene Holding Co., Ltd.
Giant Biogene Holding Co., Ltd. is an investment holding company specializing in the research, development, manufacture, and sale of bioactive material-based beauty and health products. Headquartered in Xi'an, China, the company has been a key player in the industry since its founding in 2000.
Core Business Activities
- Manufactures rare ginsenosides technology-based functional foods.
- Provides medical devices and skincare solutions.
- Develops bioactive products for beauty and health applications.
Brand Portfolio
The company markets its products under well-known brands, including:
- Comfy – Functional skincare products.
- Collgene – Medical dressings and advanced skincare.
- Keyu & SKIGIN – Functional foods and specialized health solutions.
With a strong presence in China, Giant Biogene continues to innovate in the beauty and health sectors, leveraging bioactive materials for high-quality consumer products.
Frequently Asked Questions
-
What is Giant Biogene Holding's (HKG-2367) current market cap?As of 10/20/2025, Giant Biogene Holding (including the parent company, if applicable) has an estimated market capitalization of $5.63 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.
-
Where does Giant Biogene Holding (HKG-2367) rank globally by market cap?Giant Biogene Holding global market capitalization ranking is approximately 3219 as of 10/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.